PolyNovo Limited (ASX: PNV)
Health Care · Health Care Equipment & Supplies · AU
AU$1.07
-3.60% today · -2.7% 1Y
PolyNovo Limited (ASX: PNV) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $529.86M and employs 301 people.
Over the last twelve months the share price has lost 2.7%, trading between 0.81 and 1.67.
Tweenvest scores PolyNovo Limited across four factors: quality 69/100, value 48/100, growth 100/100. Its strongest factor is growth.
PNV price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $529.86M
- Revenue (TTM)
- $93.04M
- P/E
- 76.04
- EPS
- 0.01
- Dividend yield
- —
- Beta (5Y)
- 1.35
- 52-week high
- AU$1.67
- 52-week low
- AU$0.81
- Avg volume (3M)
- —
- Shares outstanding
- 690.84M
- Employees
- 301
- Next earnings
- —
About PolyNovo Limited
PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in Australia, New Zealand, the United States, the United Kingdom, Ireland, Singapore, India, and Hong Kong. The company offers NovoSorb Biodegradable Temporising Matrix, a dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma, or burn. It is also developing hernia devices for hernia repair and solution for ventral hernia and complex abdominal wall reconstruction; Beta Cell implant, a novel intracutaneous ectopic pancreas to treat type 1 diabetes; NovoSorb MTX for single stage grafting in burns, chronic, and surgical wounds; and plastics and reconstructive device products. The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014. PolyNovo Limited was incorporated in 1998 and is headquartered in Port Melbourne, Australia.
- ISIN
- AU000000PNV0
- Founded
- 1998
- Listed since
- Nov 29, 1998
- Exchange
- Australian Securities Exchange
- Currency
- AUD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $201.83B | $116.64 | +2.19% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $133.83B | $378.81 | +1.19% |
| Stryker CorporationNYSE: SYK | $126.37B | $329.45 | +0.53% |
| Medtronic plcNYSE: MDT | $119.49B | $93.35 | +1.14% |
| EssilorLuxottica Société anonymeENXTPA: EL | $87.56B | €163.20 | +1.24% |
| Boston Scientific CorporationNYSE: BSX | $73.00B | $50.37 | +2.03% |
| HOYA CorporationTSE: 7741 | $52.38B | ¥24,895.00 | -1.37% |
| Becton, Dickinson and CompanyNYSE: BDX | $52.30B | $192.00 | +2.33% |
Figures last refreshed Aug 18, 2026.